Floatz logo

METHOTREXATE

Child

The Korean Society of Pediatric Hematology OncologySmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

9 Active assets in the Child cohort.

Asset / SponsorPhaseRating
Thiamine
Mahidol University
Phase 4BB
Emicizumab
Kathelijn Fischer
Phase 4B
Bedamustine
Children's Cancer Group, China
Phase 2/3B
Inno-206
Children's Cancer Group, China
Phase 2/3B
PREDNISONE TABLETS
Children's Cancer Group, China
Phase 2/3B

View all 12 →

Same molecule, other indications

METHOTREXATE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
acute promyelocytic leukemiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →